Many breast imaging facilities in the United States lack policies that focus on providing friendly, inclusive care to transgender patients, according to a new study published in the Journal of the American College of Radiology.

New 2018 guidelines for myocardial perfusion imaging (MPI) protocols on conventional and novel single photon emission computed tomography (SPECT) for nuclear cardiology practitioners has received praise from the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

Company Combines Diverse Imaging Portfolio with Commitment to Continued Innovation

LeAnn Shannon, MD, a second-year diagnostic radiology resident at Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee, has been awarded the American Roentgen Ray Society (ARRS) 2018 Certificate of Merit for her exhibit at the 118th ARRS Annual Meeting in Washington, D.C.

CHICAGO – With well-documented gaps in health and health care across segments of the United States, the American Medical Association (AMA) today adopted policy during its Annual Meeting to define health equity and outline a strategic framework toward realizing the goal of achieving optimal health for all, referring to all aspects of health, including mental and behavioral health. To begin down that path, the AMA will establish a structural or organizational home for the effort, complete with dedicated resources, staff and budget, and a multi-year programmatic roadmap.

The Medical Imaging and Technology Alliance (MITA) announced its strong support of a bipartisan letter from U.S. Reps. Erik Paulsen, R-Minnesota, and Scott Peters, D-California, urging United States Trade Representative (USTR) Robert Lighthizer to exempt $3 billion worth of medical devices from tariffs.

WAYNE, N.J., May 25, 2018 — Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia Following IABP Implantation (SEMPER FI) pilot study.

An investigational transcatheter mitral valve replacement (TMVR) device helped reduce mitral regurgitation to zero or trace levels in 98.7 percent of patients, according to 30-day follow-up data from the first 100 people scheduled to be treated with Abbott’s Tendyne system.